Figure 2From: A novel biomarker TERTmRNA is applicable for early detection of hepatoma Serum hTERTmRNA and AFP mRNA expression in patients with HCC, LC, and CH, and in healthy individuals and receiver operator characteristics (ROC) curve analyses of hTERTmRNA, AFP, AFP-L3, and DCP. A. hTERTmRNA level in liver diseases. Serum hTERTmRNA levels and AFPmRNA level in patients with HCC, LC, CH, and healthy individuals by real-time RT-PCR were shown. The 95% confidence interval in each group is shown beside the dots. Significant differences between 4 groups are shown in the upper part of the figure. NL, individual with normal liver; CH, chronic hepatitis; LC, liver cirrhosis; HCC, hepatocellular carcinoma. Optimal cut-off values for hTERTmRNA expressions were predicted as 9,332 copies/0.2 ml. B. ROC curve analysis of hTERTmRNA, AFP, AFP-L3, and DCP was obtained by importing quantified raw data into SPSS II software. The data were analyzed by Paired t test (P = 0.01) and non-parametric Spearman's test (P = 0.017). AUC of each biomarker in ROC curve analysis is shown. Receiver operator characteristic (ROC) curve analysis of hTERTmRNA, AFP, AFP-L3, and DCP was obtained by importing quantified raw data into SPSS II. The solid line, bold dotted line, dotted line, and bold solid line correspond to DCP, AFP, AFP-L3 and hTERTmRNA, respectively.Back to article page